All Curated Mutation Sites in EBV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in EBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
LMP-1
  
BZLF1
  
EBNA-1
  
EBNA-2
  
EBNA-3A
  
EBNA-3B/EBNA-3C
  
LMP-2A
  
LMP-2
  
EBNA-2
  
BARF1
  
BALF2
  
BXLF1
  
BPLF1
  
BcRF1
  
BFRF2
  
BILF1
  
BLLF1
  
BMRF1
  
BNRF1
  
BOLF1
  
BRRF2
  
LF1
  

Keyword: BRRF2
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 25933165 F477L
BRRF2
BRRF2
Cell line
R
L
View
2 25933165 I537V
BRRF2
BRRF2
Cell line
R
L
View
3 25933165 D464E
BRRF2
BRRF2
Cell line
R
L
View
4 25933165 D463A
BRRF2
BRRF2
Cell line
R
L
View
5 25933165 E464D
BRRF2
BRRF2
Cell line
R
L
View
6 33212090 M385T
BRRF2
BRRF2
Cholangiocarcinoma
R
S
L
View
7 33212090 K392Q
BRRF2
BRRF2
Cholangiocarcinoma
R
S
L
View
8 33212090 E395G
BRRF2
BRRF2
Cholangiocarcinoma
R
S
L
View
9 33212090 V315G
BRRF2
BRRF2
Cholangiocarcinoma
R
S
L
View
10 33212090 S325L
BRRF2
BRRF2
Cholangiocarcinoma
R
S
L
View
11 30546078 D261N
BRRF2
BRRF2
Lymphoma, Extranodal NK-T-Cell
R
L
View
12 30546078 A427S
BRRF2
BRRF2
Lymphoma, Extranodal NK-T-Cell
R
L
View
13 31481499 E257G
BRRF2
BRRF2
Nasopharyngeal Carcinoma
View
14 31481499 F284L
BRRF2
BRRF2
Nasopharyngeal Carcinoma
View
15 31481499 M385L
BRRF2
BRRF2
Nasopharyngeal Carcinoma
View
16 31481499 P276Q
BRRF2
BRRF2
Nasopharyngeal Carcinoma
View
17 31481499 R333L
BRRF2
BRRF2
Nasopharyngeal Carcinoma
View
18 31481499 T110R
BRRF2
BRRF2
Nasopharyngeal Carcinoma
View
19 31481499 T374K
BRRF2
BRRF2
Nasopharyngeal Carcinoma
View
20 31481499 V296G
BRRF2
BRRF2
Nasopharyngeal Carcinoma
View
21 31481499 D463H
BRRF2
BRRF2
Nasopharyngeal Carcinoma
Lymphoma, Large B-Cell, Diffuse
View
22 31481499 D474V
BRRF2
BRRF2
Nasopharyngeal Carcinoma
Lymphoma, Large B-Cell, Diffuse
View
23 31481499 E395G
BRRF2
BRRF2
Nasopharyngeal Carcinoma
Lymphoma, Large B-Cell, Diffuse
View
24 31481499 F430L
BRRF2
BRRF2
Nasopharyngeal Carcinoma
Lymphoma, Large B-Cell, Diffuse
View
25 31481499 H196L
BRRF2
BRRF2
Nasopharyngeal Carcinoma
Lymphoma, Large B-Cell, Diffuse
View
26 31481499 H313D
BRRF2
BRRF2
Nasopharyngeal Carcinoma
Lymphoma, Large B-Cell, Diffuse
View
27 29093097 T374A
BRRF2
BRRF2
Stomach Neoplasms
R
S
View
28 29093097 Q285K
BRRF2
BRRF2
Stomach Neoplasms
R
S
View
29 29093097 H313R
BRRF2
BRRF2
Stomach Neoplasms
R
S
View
30 29093097 S325L
BRRF2
BRRF2
Stomach Neoplasms
R
S
View
31 29093097 K392Q
BRRF2
BRRF2
Stomach Neoplasms
R
S
View
32 29093097 F430S
BRRF2
BRRF2
Stomach Neoplasms
R
S
View
33 29093097 D463A
BRRF2
BRRF2
Stomach Neoplasms
R
S
View
Contents
Description

The table shows all curated mutation sites of EBV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.